Cargando…
Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital
BACKGROUND: Community-acquired pneumonia (CAP) is a common cause of pediatric admission to hospital. The objectives of this study were twofold: 1) to describe the clinical characteristics of CAP in children admitted to a tertiary care pediatric hospital in the pneumococcal vaccination era and, 2) to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477073/ https://www.ncbi.nlm.nih.gov/pubmed/22928588 http://dx.doi.org/10.1186/1471-2431-12-133 |
_version_ | 1782247180998803456 |
---|---|
author | Rowan-Legg, Anne Barrowman, Nicholas Shenouda, Nazih Koujok, Khaldoun Le Saux, Nicole |
author_facet | Rowan-Legg, Anne Barrowman, Nicholas Shenouda, Nazih Koujok, Khaldoun Le Saux, Nicole |
author_sort | Rowan-Legg, Anne |
collection | PubMed |
description | BACKGROUND: Community-acquired pneumonia (CAP) is a common cause of pediatric admission to hospital. The objectives of this study were twofold: 1) to describe the clinical characteristics of CAP in children admitted to a tertiary care pediatric hospital in the pneumococcal vaccination era and, 2) to examine the antimicrobial selection in hospital and on discharge. METHODS: A retrospective review of healthy immunocompetent children admitted to a tertiary pediatric hospital from January 2007 to December 2008 with clinical features consistent with pneumonia and a radiographically-confirmed consolidation was performed. Clinical, microbiological and antimicrobial data were collected. RESULTS: One hundred and thirty-five hospitalized children with pneumonia were evaluated. Mean age at admission was 4.8 years (range 0–17 years). Two thirds of patients had been seen by a physician in the 24 hours prior to presentation; 56 (41.5%) were on antimicrobials at admission. 52 (38.5%) of patients developed an effusion, and 22/52 (42.3%) had pleural fluid sampled. Of 117 children who had specimens (blood/pleural fluid) cultured, 9 (7.7%) had pathogens identified (7 Streptococcus pneumoniae, 1 Group A Streptococcus, and 1 Rhodococcus). 55% of patients received 2 or more antimicrobials in hospital. Cephalosporins were given to 130 patients (96.1%) in hospital. Only 21/126 patients (16.7%) were discharged on amoxicillin. The median length of stay was 3 days (IQR 2–4) for those without effusion and 9 (IQR 5–13) for those with effusion. No deaths were related to pneumonia. CONCLUSIONS: This study provides comprehensive data on the clinical characteristics of hospitalized children with CAP in the pneumococcal 7-valent vaccine era. Empiric antimicrobial choice at our institution is variable, highlighting a need for heightened antimicrobial stewardship. |
format | Online Article Text |
id | pubmed-3477073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34770732012-10-20 Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital Rowan-Legg, Anne Barrowman, Nicholas Shenouda, Nazih Koujok, Khaldoun Le Saux, Nicole BMC Pediatr Research Article BACKGROUND: Community-acquired pneumonia (CAP) is a common cause of pediatric admission to hospital. The objectives of this study were twofold: 1) to describe the clinical characteristics of CAP in children admitted to a tertiary care pediatric hospital in the pneumococcal vaccination era and, 2) to examine the antimicrobial selection in hospital and on discharge. METHODS: A retrospective review of healthy immunocompetent children admitted to a tertiary pediatric hospital from January 2007 to December 2008 with clinical features consistent with pneumonia and a radiographically-confirmed consolidation was performed. Clinical, microbiological and antimicrobial data were collected. RESULTS: One hundred and thirty-five hospitalized children with pneumonia were evaluated. Mean age at admission was 4.8 years (range 0–17 years). Two thirds of patients had been seen by a physician in the 24 hours prior to presentation; 56 (41.5%) were on antimicrobials at admission. 52 (38.5%) of patients developed an effusion, and 22/52 (42.3%) had pleural fluid sampled. Of 117 children who had specimens (blood/pleural fluid) cultured, 9 (7.7%) had pathogens identified (7 Streptococcus pneumoniae, 1 Group A Streptococcus, and 1 Rhodococcus). 55% of patients received 2 or more antimicrobials in hospital. Cephalosporins were given to 130 patients (96.1%) in hospital. Only 21/126 patients (16.7%) were discharged on amoxicillin. The median length of stay was 3 days (IQR 2–4) for those without effusion and 9 (IQR 5–13) for those with effusion. No deaths were related to pneumonia. CONCLUSIONS: This study provides comprehensive data on the clinical characteristics of hospitalized children with CAP in the pneumococcal 7-valent vaccine era. Empiric antimicrobial choice at our institution is variable, highlighting a need for heightened antimicrobial stewardship. BioMed Central 2012-08-28 /pmc/articles/PMC3477073/ /pubmed/22928588 http://dx.doi.org/10.1186/1471-2431-12-133 Text en Copyright ©2012 Rowan-Legg et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Rowan-Legg, Anne Barrowman, Nicholas Shenouda, Nazih Koujok, Khaldoun Le Saux, Nicole Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title | Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title_full | Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title_fullStr | Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title_full_unstemmed | Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title_short | Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital |
title_sort | community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a canadian pediatric hospital |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477073/ https://www.ncbi.nlm.nih.gov/pubmed/22928588 http://dx.doi.org/10.1186/1471-2431-12-133 |
work_keys_str_mv | AT rowanlegganne communityacquiredlobarpneumoniainchildrenintheeraofuniversal7valentpneumococcalvaccinationareviewofclinicalpresentationsandantimicrobialtreatmentfromacanadianpediatrichospital AT barrowmannicholas communityacquiredlobarpneumoniainchildrenintheeraofuniversal7valentpneumococcalvaccinationareviewofclinicalpresentationsandantimicrobialtreatmentfromacanadianpediatrichospital AT shenoudanazih communityacquiredlobarpneumoniainchildrenintheeraofuniversal7valentpneumococcalvaccinationareviewofclinicalpresentationsandantimicrobialtreatmentfromacanadianpediatrichospital AT koujokkhaldoun communityacquiredlobarpneumoniainchildrenintheeraofuniversal7valentpneumococcalvaccinationareviewofclinicalpresentationsandantimicrobialtreatmentfromacanadianpediatrichospital AT lesauxnicole communityacquiredlobarpneumoniainchildrenintheeraofuniversal7valentpneumococcalvaccinationareviewofclinicalpresentationsandantimicrobialtreatmentfromacanadianpediatrichospital |